This review synthesizes clinical evidence on Serenoa repens efficacy and safety in benign prostatic hyperplasia and associated lower urinary tract symptoms, highlighting mixed findings and mechanistic insights from randomized trials and meta-analyses.

Recent high-quality evidence indicates that Serenoa repens provides little to no benefit for lower urinary tract symptoms due to benign prostatic enlargement compared to placebo.